首页|期刊导航|食品科学与人类健康（英文）|Apple polyphenol phloretin inhibits type Ⅱ glucose transporter and enhances anti-HER2 antibody drug binding as an adjuvant treatment for HER2-positive breast cancer

Apple polyphenol phloretin inhibits type Ⅱ glucose transporter and enhances anti-HER2 antibody drug binding as an adjuvant treatment for HER2-positive breast cancer

Han-Sheng Chang Tzu-Chun Cheng Shih-Hsin Tu Pei-Han Liao Yu-Ching Lee Chi-Tang Ho Min-Hsiung Pan Li-Ching Chen Yuan-Soon Ho

食品科学与人类健康（英文）2025，Vol.14Issue(4)：1264-1280,17.

食品科学与人类健康（英文）2025，Vol.14Issue(4)：1264-1280,17.DOI:10.26599/FSHW.2024.9250251

Apple polyphenol phloretin inhibits type Ⅱ glucose transporter and enhances anti-HER2 antibody drug binding as an adjuvant treatment for HER2-positive breast cancer

Han-Sheng Chang ¹Tzu-Chun Cheng ²Shih-Hsin Tu ³Pei-Han Liao ¹Yu-Ching Lee ⁴Chi-Tang Ho ⁵Min-Hsiung Pan ⁶Li-Ching Chen ¹Yuan-Soon Ho²

作者信息

1. Department of Biological Science&Technology,College of Life Sciences,China Medical University,Taichung 404,Taiwan,China
2. Institute of Biochemistry and Molecular Biology,College of Life Sciences,China Medical University,Taichung 404,Taiwan,China
3. Department of Surgery,School of Medicine,College of Medicine,Taipei Medical University,Taipei 11031,Taiwan,China
4. Research Center of Cancer Translational Medicine,Taipei Medical University,Taipei 11031,Taiwan,China
5. Department of Food Science,Rutgers University,New Jersey 08901,USA
6. Institute of Food Sciences and Technology,National Taiwan University,Taipei 10617,Taiwan,China
折叠

摘要

关键词

Type II glucose transporter(GLUT2)/Phloretin/Human epidermal growth factor receptor/2-intracellular domain(HER2-ICD)/Trastuzumab/Trastuzumab-resistance

Key words

Type II glucose transporter(GLUT2)/Phloretin/Human epidermal growth factor receptor/2-intracellular domain(HER2-ICD)/Trastuzumab/Trastuzumab-resistance

引用本文复制引用

Han-Sheng Chang,Tzu-Chun Cheng,Shih-Hsin Tu,Pei-Han Liao,Yu-Ching Lee,Chi-Tang Ho,Min-Hsiung Pan,Li-Ching Chen,Yuan-Soon Ho..Apple polyphenol phloretin inhibits type Ⅱ glucose transporter and enhances anti-HER2 antibody drug binding as an adjuvant treatment for HER2-positive breast cancer[J].食品科学与人类健康（英文）,2025,14(4):1264-1280,17.

基金项目

This study was supported by the National Science and Technology Council,Taiwan,China(NSTC 112-2320-B-039-057 and MOST 111-2320-B-039-067-MY3),the China Medical University,Taiwan,China(CMU112-S-18),awarded to Yuan-Soon Ho,the National Science and Technology Council,Taiwan,China(MOST 110-2320-B-039-079),and the China Medical University,Taiwan,China(CMU112-N-02),awarded to Li-Ching Chen. （NSTC 112-2320-B-039-057 and MOST 111-2320-B-039-067-MY3）

食品科学与人类健康（英文）

访问量0

下载量0

段落导航